📗 Cite This Artifact
CNTN2 — Contactin 2
CNTN2 — Contactin 2
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CNTN2 — Contactin 2</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CNTN2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Contactin 2 (axonin-1, TAG-1)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q32.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6900</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>164395</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000167644</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9H5Y1</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,438 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~160 kDa</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in brain (hippocampus, cerebellum, cortex), developing neurons, oligodendrocyte precursors</td>
</tr>
<tr>
<td class="label">Aspect</td>
<td>Details</td>
</tr>
<tr>
<td class="label">Genetic variants</td>
<td>R1026X, D1195N, and other missense variants</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Altered neuronal migration, network hyperexcitability, impaired GABAergic function</td>
</tr>
<tr>
<td class="label">Evidence</td>
<td>GWAS studies show association; expression altered in epileptic tissue</td>
</tr>
<tr>
<td class="label">Population<
CNTN2 — Contactin 2
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CNTN2 — Contactin 2</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CNTN2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Contactin 2 (axonin-1, TAG-1)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q32.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6900</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>164395</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000167644</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9H5Y1</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,438 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~160 kDa</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in brain (hippocampus, cerebellum, cortex), developing neurons, oligodendrocyte precursors</td>
</tr>
<tr>
<td class="label">Aspect</td>
<td>Details</td>
</tr>
<tr>
<td class="label">Genetic variants</td>
<td>R1026X, D1195N, and other missense variants</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Altered neuronal migration, network hyperexcitability, impaired GABAergic function</td>
</tr>
<tr>
<td class="label">Evidence</td>
<td>GWAS studies show association; expression altered in epileptic tissue</td>
</tr>
<tr>
<td class="label">Population</td>
<td>Both sporadic and familial cases reported</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Contactin 2 (CNTN2), also known as TAG-1 (Transient Axonal Glycoprotein-1) or axonin-1, is a neuronal surface glycoprotein belonging to the immunoglobulin superfamily of neural cell adhesion molecules. CNTN2 plays pivotal roles in nervous system development, including axon guidance, neuronal migration, synaptogenesis, and myelination. It has been implicated in the pathogenesis of epilepsy, autism spectrum disorder (ASD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) [@stoe1994][@furley1991].
CNTN2 is a glycosylphosphatidylinositol (GPI)-anchored protein that interacts with various partners including NrCAM, Neurofascin, L1CAM, and DCC/neogenin to orchestrate critical developmental processes. Its expression pattern spans both the developing and adult nervous system, with particularly high levels in the hippocampus, cerebellum, and cerebral cortex [@anagnostou2010][@kurosaki2020].
Gene Information
Normal Function
Molecular Structure
CNTN2 is a member of the contactin family of immunoglobulin superfamily proteins. Its structure includes:
This modular structure enables CNTN2 to function as a versatile cell adhesion molecule capable of mediating multiple protein-protein interactions [@furley1991][@zhao2023].
Developmental Functions
Axon Guidance
CNTN2 is a critical player in axonal pathfinding during development. It acts as a guidance cue for extending axons by:
- Commissural neuron guidance: CNTN2 expression along the midline guides commissural axons across the floor plate
- Corticospinal tract development: Facilitates proper formation of the corticospinal motor pathway
- Retinotectal mapping: Regulates topographic mapping in the visual system
- Olfactory system development: Involved in olfactory circuit formation
The protein interacts with the DCC/neogenin receptors to transduce guidance signals through the cytoskeleton [@stoe1994][@kurosaki2020].
Neuronal Migration
During cortical development, CNTN2 facilitates:
- Radial migration: Guides neurons along radial glia during cortical layer formation
- Tangential migration: Supports interneuron migration in the developing cortex
- Layer-specific positioning: Ensures proper laminar organization of the cerebral cortex
Mutations affecting CNTN2 function disrupt these migration processes, contributing to neurodevelopmental disorders [@buttermiller2016][@karayazi2024].
Synapse Formation and Function
CNTN2 plays essential roles in synaptogenesis and synaptic plasticity:
- Excitatory synapse development: Promotes formation of glutamatergic synapses
- Synaptic stability: Maintains synaptic contacts through interaction with postsynaptic partners
- Synaptic plasticity: Modulates activity-dependent structural changes at synapses
- Dendritic spine morphology: Regulates spine shape and density
These functions explain CNTN2's involvement in ASD and other neurodevelopmental conditions [@mercati2015][@zhao2023].
Myelination and Oligodendrocyte Function
In the white matter, CNTN2 regulates:
- Oligodendrocyte precursor cell (OPC) migration: Guides OPCs to proper locations during development
- Myelination: Regulates the myelination process
- Node of Ranvier organization: Localizes at paranodal regions to organize the nodes
Dysregulation of these functions contributes to demyelinating disorders like MS [@zonouzi2017][@liu2021].
Signaling Mechanisms
CNTN2 signals through multiple downstream pathways:
Disease Associations
Epilepsy
CNTN2 is strongly associated with epilepsy susceptibility and has been identified as a risk factor for multiple seizure disorders:
Studies demonstrate reduced CNTN2 expression in hippocampal sclerosis and cortical dysplasia specimens from patients with temporal lobe epilepsy. The protein's role in neuronal migration and circuit formation means that developmental dysregulation can create hyperexcitable networks prone to spontaneous seizures [@anagnostou2010][@savas2018][@kurosaki2020].
Autism Spectrum Disorder (ASD)
CNTN2 variants contribute to ASD risk through synaptic dysfunction:
- Impaired synapse formation leads to defective neural circuitry
- Altered social behavior and communication in mouse models
- CNTN2 haploinsufficiency associated with mild intellectual disability
- Gene-environment interactions may modify risk
Mouse models with CNTN2 knockout show reduced social interactions, impaired vocalizations, and repetitive behaviors—core ASD phenotypes [@mercati2015][@buttermiller2016].
Multiple Sclerosis
CNTN2 acts as a disease modifier in MS:
- Alters oligodendrocyte function and myelination
- CNTN2 polymorphisms associated with disease susceptibility
- Expression changes in demyelinating lesions
- Potential for therapeutic targeting in remyelination
Genetic studies have identified CNTN2 variants that influence MS risk and progression [@zonouzi2017][@liu2021].
Amyotrophic Lateral Sclerosis (ALS)
Emerging evidence links CNTN2 to ALS:
- Motor neuron-specific vulnerability in CNTN2-deficient mice
- Altered axonal integrity in models
- Potential therapeutic target for preserving motor neurons
- Interaction with other ALS-associated proteins
The protein's role in axonal maintenance makes it relevant to the dying-back pattern of motor neuron degeneration seen in ALS [@chen2022].
Alzheimer's Disease
While less well-characterized, CNTN2 may contribute to AD pathogenesis through:
- Synaptic dysfunction in early disease stages
- Possible interactions with amyloid and tau pathology
- Altered expression in AD brain tissue
Therapeutic Approaches
Small Molecule Modulators
- Cell adhesion enhancers: Promote CNTN2-mediated synaptic connectivity
- GABAergic modulators: Address network hyperexcitability in epilepsy
- Neuroprotective agents: Target downstream pathways
Antibody-Based Therapies
- CNTN2-neutralizing antibodies: Modulate abnormal interactions
- Engineered adhesion molecules: Artificial CNTN2 mimetics
Gene Therapy
- AAV-mediated CNTN2 delivery: Restore function in deficiency states
- CRISPR-based approaches: Correct pathogenic variants
- Antisense oligonucleotides: Reduce toxic variants
Regenerative Approaches
- Oligodendrocyte modulators: Enhance remyelination in MS
- OPC migration enhancers: Promote repair
- Synaptic reconstruction: Activity-dependent plasticity enhancers
Animal Models
- CNTN2 knockout mice: Show developmental abnormalities, seizures, and social deficits
- Conditional knockouts: Cell-type specific models reveal tissue-specific functions
- Transgenic models: Express human disease-associated variants
- Zebrafish models: Simple in vivo system for developmental studies
Cross-Links
- [Epilepsy](/diseases/epilepsy) — Primary disease association
- [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder) — Related neurodevelopmental disorder
- [Multiple Sclerosis](/diseases/multiple-sclerosis) — Disease modifier
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — Emerging association
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Possible role
- [Axon Guidance Pathway](/mechanisms/axon-guidance) — Normal function
- [Synaptogenesis Pathway](/mechanisms/synaptogenesis) — Synaptic function
- [Myelination Pathway](/mechanisms/myelination) — Oligodendrocyte function
Key Publications
See Also
- [Neural Cell Adhesion Molecules](/mechanisms/neural-cell-adhesion-molecules)
- [Axon Guidance](/mechanisms/axon-guidance)
- [Synaptogenesis](/mechanisms/synaptogenesis)
- [Epilepsy Mechanisms](/diseases/epilepsy)
- [Neurodevelopment](/mechanisms/neurodevelopment)
- [Myelination](/mechanisms/myelination)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-cntn2 |
| kg_node_id | CNTN2 |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-61cae755ee39 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-cntn2'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-cntn2?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[CNTN2 — Contactin 2](http://scidex.ai/artifact/wiki-genes-cntn2)
http://scidex.ai/artifact/wiki-genes-cntn2